Biotricity Inc (NQ: BTCY )
0.8501 -0.0099 (-1.15%) Streaming Delayed Price Updated: 1:44 PM EST, Nov 28, 2023 Add to My Watchlist
All News about Biotricity Inc
Biotricity to Present at the 2022 H.C. Wainwright Global Investment Conference on Tuesday May 24th
May 23, 2022
REDWOOD CITY, CA / ACCESSWIRE / May 23, 2022 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, is scheduled to present...
Biotricity to Launch Commercial Sales of Its Disruptive Cardiac Monitoring Device, Biotres in April 2022
March 22, 2022
- Company reports pre-order sales from existing customers of its wireless wearable device for early detection of cardiac arrhythmias REDWOOD CITY, CA / ACCESSWIRE / March 22, 2022 / Biotricity, Inc....
Biotricity Named to Fast Company's Annual List of the World's 50 Most Innovative Companies for 2022
March 08, 2022
Leader in early-detection cardiac diagnostics monitoring solutions joins the ranks of Canva, Microsoft, SpaceX, and more REDWOOD CITY, CA / ACCESSWIRE / March 8, 2022 / Biotricity, Inc. (NASDAQ:BTCY)...
- Follows fiscal third quarter earnings that saw revenue up 93% year-over-year and Company's highest-ever quarterly cash position - Biotricity now taking preorders for Biotres, an FDA-cleared,...
Biotricity Now Taking Pre-Orders for its Biotres Wireless Wearable Cardiac Monitoring Device
February 23, 2022
- Announcement follows FDA clearance - Pre-Orders begin on February 23, 2022 with units shipping April 1, 2022 REDWOOD CITY, CA / ACCESSWIRE / February 23, 2022 / Biotricity, Inc. (NASDAQ:BTCY)...
Biotricity Releases Fiscal 2022 Third Quarter Financial Results
February 14, 2022
Management to host investor call on Tuesday February 15th at 4:15 pm ET - 93% YOY Revenue Gains to $1.93 Million - Revenue Outpaces SG&A Increase by 2.2x - Cash Position of $16.8 Million at Quarter End...
Biotricity to Report Third Quarter Fiscal 2022 Financial Results on February 14, 2022
February 08, 2022
Management to host call on Tuesday, February 15th at 4:15pm ET Sees Calendar-2022 as a breakout year with commercial launch of Bioheart and FDA clearance for Biotres REDWOOD CITY, CA / ACCESSWIRE /...
Biotres is designed to continuously record ECG data for early detection of cardiac arrhythmias The Biotres addresses the $2 Billion-dollar holter market REDWOOD CITY, CA / ACCESSWIRE / January 24, 2022...
Biotricity Expands Distribution of New Bioheart Device on Amazon.com
December 28, 2021
New Heart Monitoring Solution Delivers Personalized Heart Health Insights Directly to Your Smartphone Now Easy to Buy and Use: No Prescription Needed for Advanced Heart and Lifestyle Solution REDWOOD...
Biotricity Completes $12 Million Non-Dilutive Debt Financing
December 27, 2021
Capital infusion to finance inventory and annual recurring revenue subscriptions replaces expiring debt with more favorable terms 5-year term deal strengthens balance sheet, positions company for...
Biotricity, a Leader in Remote Cardiac Health Monitoring Solutions, Issues Company Roadmap in 2021 Shareholder Letter
December 07, 2021
The Company believes that it is "well-positioned for 2022." Letter highlights milestones, products roadmap, growth strategy and 2022 goals REDWOOD CITY, CA / ACCESSWIRE / December 7, 2021 / Biotricity,...
Topics Regulatory Compliance